Connection
Michael Verneris to Cell- and Tissue-Based Therapy
This is a "connection" page, showing publications Michael Verneris has written about Cell- and Tissue-Based Therapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.143 |
|
|
|
-
Cobb LM, Verneris MR. Therapeutic manipulation of innate lymphoid cells. JCI Insight. 2021 03 22; 6(6).
Score: 0.633
-
Verneris MR, Grupp SA. Natural killer cell consolidation for acute myelogenous leukemia: a cell therapy ready for prime time? J Clin Oncol. 2010 Feb 20; 28(6):909-10.
Score: 0.292
-
Adams C, Keller M, Michlitsch JG, Aguayo-Hiraldo P, Chen K, Hossain MZ, Davis A, Park JR, Verneris MR, Gardner RA. Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy. Transplant Cell Ther. 2024 05; 30(5):475-487.
Score: 0.194
-
Knorr DA, Bachanova V, Verneris MR, Miller JS. Clinical utility of natural killer cells in cancer therapy and transplantation. Semin Immunol. 2014 Apr; 26(2):161-72.
Score: 0.024